Join SightNation!

Become a citizen of our interactive community. Collaborate and network with your colleagues and trusted peers. Membership is free!

Connect with Colleagues

Link up with professionals all over the nation. Share your ideas, thoughts and opinions. Collaborate on difficult cases and offer your insights.

Communicate and Educate

Discuss new and important issues with your colleagues. Share your insights to help improve patient counseling. Post questions to your peers.

Learn and Advance

Take CE courses and rate courses for your peers. Find and apply for the newest jobs. Stay up-to-date on the latest eye care industry news.


Engage with SightNation citizens to help create real reform on issues affecting the industry. Start or join groups about the issues most important to you.

Create an account and receive access to the personalized box below.

Apply for Citizenship!
Local Eye Site
view counter

What’s Going On Across the Nation

New Blog Postings

SightNation News

Featured News

FDA Approves Eylea for the Treatment of Diabetic Retinopathy in Patients with DME - 03.30.2015

Regeneron Pharmaceuticals Inc. announced that the FDA has approved Eylea (aflibercept) Injection for the treatment of diabetic retinopathy in patients with diabetic macular edema. More »

Featured News

IRIDEX Announces First Commercial Sales of New Cyclo G6 Glaucoma Laser Systems - 03.26.2015

Iridex Corp. has reported the first commercial sales of its new Cyclo G6 laser system, designed to treat patients diagnosed with a range of glaucoma disease states. More »

Featured News

Efficacy and Safety Results Reported in Non-Infectious Uveitis Using a Single Suprachoroidal Injection of Triamcinolone Acetonide - 03.25.2015

Clearside Biomedical Inc. recently shared the efficacy and safety results from its recently completed six-month Phase I/II clinical trial. More »

Kellogg Center Study Finds Generics Improve Adherence - 03.23.2015

When patients with glaucoma switched from a brand name drug to its generic counterpart, they were more likely to take their medication as directed compared to those who remained on the brand name drug More »

Copyright © 2010 Jobson Medical Information LLC. All Rights Reserved.